Lindholm T C, Lindholm T S, Nilsson O S, Sjökvist G
Scand J Rheumatol. 1986;15(1):68-74. doi: 10.3109/03009748609092671.
We report the effects of 1 alpha-OH-D3 and 24,25(OH)2D3, either alone or combined, on new bone formation induced by demineralized cortical bone matrix transplanted extraskeletally to the abdominal muscle wall in rats. 1 alpha-OH-D3 was administered orally in dosages of 0.1 microgram, 24,25(OH)2D3 in dosages of 0.2 micrograms, and, in the combined procedure, in the same dosages as mentioned above per day and rat. The amount of induced new bone in respect of organic matter, mineral content and 45Ca activity increased in all treatment groups, compared with controls. The differences between the groups treated separately with 1 alpha-OH-D3 or 24,25(OH)2D3 were insignificant. The differences in the combined treatment group were not so profound, but differed considerably compared with controls. However, 1 alpha-OH-D3 showed more prominent effects on the mineralization of implanted grafts, while 24,25(OH)2D3 especially promoted the production of organic material of the newly formed bone.
我们报告了1α-羟基维生素D3和24,25-二羟基维生素D3单独或联合使用,对脱矿皮质骨基质异位移植到大鼠腹部肌肉壁诱导新骨形成的影响。1α-羟基维生素D3按每天每只大鼠0.1微克的剂量口服,24,25-二羟基维生素D3按每天每只大鼠0.2微克的剂量口服,联合用药时,每天每只大鼠的剂量与上述相同。与对照组相比,所有治疗组诱导新骨的有机质、矿物质含量和45Ca活性均增加。单独使用1α-羟基维生素D3或24,25-二羟基维生素D3治疗的组间差异不显著。联合治疗组的差异没有那么显著,但与对照组相比有很大差异。然而,1α-羟基维生素D3对植入移植物的矿化作用更为显著,而24,25-二羟基维生素D3特别促进新形成骨的有机物质生成。